In "Founder Story: Navigating the Path to Exit," Dr. Hubert Zajicek interviews Panna Sharma, President and CEO of Lantern Pharma. Lantern Pharma leverages A.I., machine learning, and genomics to transform the cost, pace, and timeline of oncology drug discovery and development.

This episode explores Sharma's journey through the complexities of the healthcare industry and entrepreneurship, leading to a successful exit that transformed Lantern Pharma into a publicly traded company (NASDAQ: LTRN). From the company's inception to its growth and eventual exit, listeners will gain valuable insights into Sharma's entrepreneurial vision, strategic decision-making, and the challenges he overcame along the way.